Cargando…

Identification of adjuvants for clinical trials performed with Plasmodium falciparum AMA1 in rabbits

BACKGROUND: In this study, seven adjuvants were compared for use with Plasmodium falciparum DiCo-Apical Membrane Antigen 1 (Pf-DiCo-AMA1), with the aim to identify an ideal adjuvant which yields high antibody titres and potentially broadens the responses in clinical trials. The following adjuvant fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Younis, Sumera, Faber, Bart W., Kocken, Clemens H.M., Remarque, Edmond J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664700/ https://www.ncbi.nlm.nih.gov/pubmed/31362695 http://dx.doi.org/10.1186/s12865-019-0307-y

Ejemplares similares

Immunization with different PfAMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response
por: Kusi, Kwadwo A., et al.
Publicado: (2010)

Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT™ Protects against Blood-Stage Challenge in Rhesus Macaques
por: Mahdi Abdel Hamid, Muzamil, et al.
Publicado: (2011)

Humoral Immune Responses to a Single Allele PfAMA1 Vaccine in Healthy Malaria-Naïve Adults
por: Remarque, Edmond J., et al.
Publicado: (2012)

Interplay between AMA1 immunisation and parasite challenge leads to protection against malaria infection in rhesus macaques
por: Hamid, Muzamil Mahdi Abdel, et al.
Publicado: (2010)

Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02
por: Roestenberg, Meta, et al.
Publicado: (2008)

Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
por: Kusi, Kwadwo A., et al.
Publicado: (2009)

Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
por: Sedegah, Martha, et al.
Publicado: (2010)

Accelerated phase Ia/b evaluation of the malaria vaccine candidate PfAMA1 DiCo demonstrates broadening of humoral immune responses
por: Remarque, Edmond J., et al.
Publicado: (2021)

Transgene Optimization, Immunogenicity and In Vitro Efficacy of Viral Vectored Vaccines Expressing Two Alleles of Plasmodium falciparum AMA1
por: Biswas, Sumi, et al.
Publicado: (2011)

Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
por: Thera, Mahamadou A., et al.
Publicado: (2016)

Bioinformatic Identification of Peptidomimetic-Based Inhibitors against Plasmodium falciparum Antigen AMA1
por: Alam, Asrar
Publicado: (2014)

Measurement of the plasma levels of antibodies against the polymorphic vaccine candidate apical membrane antigen 1 in a malaria-exposed population
por: Kusi, Kwadwo A, et al.
Publicado: (2012)

Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation
por: Faber, Bart W., et al.
Publicado: (2016)

Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation
por: Younis, Sumera Y., et al.
Publicado: (2018)

Low Levels of Polymorphisms and No Evidence for Diversifying Selection on the Plasmodium knowlesi Apical Membrane Antigen 1 Gene
por: Faber, Bart W., et al.
Publicado: (2015)

Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007)

Stability of the Plasmodium falciparum AMA1-RON2 Complex Is Governed by the Domain II (DII) Loop
por: Delgadillo, Roberto F., et al.
Publicado: (2016)

Malaria infection by sporozoite challenge induces high functional antibody titres against blood stage antigens after a DNA prime, poxvirus boost vaccination strategy in Rhesus macaques
por: Mahdi Abdel Hamid, Muzamil, et al.
Publicado: (2011)

Juxtamembrane Shedding of Plasmodium falciparum AMA1 Is Sequence Independent and Essential, and Helps Evade Invasion-Inhibitory Antibodies
por: Olivieri, Anna, et al.
Publicado: (2011)

Specific expression and export of the Plasmodium falciparum Gametocyte EXported Protein-5 marks the gametocyte ring stage
por: Tibúrcio, Marta, et al.
Publicado: (2015)

Correction: Juxtamembrane Shedding of Plasmodium falciparum AMA1 Is Sequence Independent and Essential, and Helps Evade Invasion-Inhibitory Antibodies
por: Olivieri, Anna, et al.
Publicado: (2012)

The RON2-AMA1 Interaction is a Critical Step in Moving Junction-Dependent Invasion by Apicomplexan Parasites
por: Lamarque, Mauld, et al.
Publicado: (2011)

Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
por: Mullen, Gregory E. D., et al.
Publicado: (2008)

Plasmodium falciparum Malaria Vaccines and Vaccine Adjuvants
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2021)

ama1 Genes of Sympatric Plasmodium vivax and P. falciparum from Venezuela Differ Significantly in Genetic Diversity and Recombination Frequency
por: Ord, Rosalynn L., et al.
Publicado: (2008)

Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity
por: Seidel-Greven, Melanie, et al.
Publicado: (2021)

Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display
por: Crossey, Erin, et al.
Publicado: (2015)

Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from Plasmodium cynomolgi to Prevent Malaria Relapse in Nonhuman Primates
por: Kim, Young Chan, et al.
Publicado: (2020)

Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children
por: Cech, Patrick Georges, et al.
Publicado: (2011)

Plasmodium vivax AMA1: Implications of distinct haplotypes for immune response
por: Bittencourt, Najara Carneiro, et al.
Publicado: (2020)

Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria
por: Peng, Heng, et al.
Publicado: (2010)

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria
por: Ganeshan, Harini, et al.
Publicado: (2016)

IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS
por: Sedegah, Martha, et al.
Publicado: (2021)

Genetic diversity of Plasmodium falciparum AMA-1 antigen from the Northeast Indian state of Tripura and comparison with global sequences: implications for vaccine development
por: Nirmolia, Tulika, et al.
Publicado: (2022)

Speakers AMA
por: CERN. Geneva
Publicado: (2019)

Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmission
por: Arnott, Alicia, et al.
Publicado: (2014)

Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1
por: Guy, Andrew J., et al.
Publicado: (2018)

Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
por: Hu, Jinhong, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5v2o2fjqv7j7g112vh8l23lli2